Imagin Medical Inc. (IMEXF)

[IMeasy]

To finance a product roll-out. If management wanted to raise a modest $10 million USD to finance some startup expenses, the share dilution is staggering. At our current .067 share price about 149,000,000 new shares would have to be issued. That would nearly double our count. Plus all the new warrants required to grease the wheels of a new venture that enjoys no guarantee of success. Of course, there are other methods of financing a new venture: venture capital, a merger/partnership,..... But, more mouths to feed may mean fewer worms for those who have been patiently waiting since mother bird Hutchins built the nest. So I suggest to my fellow long suffering shareholders to not discount a buy-out, even if it seems less than ideal. As a disclaimer: I have no knowledge of any corporate proposal to purchase IMEXF.